GRIMES & COMPANY, INC. - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 40 filers reported holding REGULUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GRIMES & COMPANY, INC. ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$26,000
+36.8%
88,203
+44.4%
0.00%0.0%
Q4 2021$19,000
-61.2%
61,076
-14.8%
0.00%
-50.0%
Q3 2021$49,000
-3.9%
71,671
+13.3%
0.00%0.0%
Q2 2021$51,000
-46.3%
63,262
+3.7%
0.00%
-60.0%
Q1 2021$95,000
+28.4%
60,991
+11.9%
0.01%
+25.0%
Q4 2020$74,000
+516.7%
54,511
+127.1%
0.00%
+300.0%
Q3 2020$12,000
-7.7%
23,998
+23.1%
0.00%0.0%
Q2 2020$13,00019,4980.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 5,555,555$1,656,0000.43%
NEA Management Company, LLC 14,451,147$4,306,0000.12%
Sarissa Capital Management LP 1,851,851$552,0000.05%
Ikarian Capital, LLC 1,289,130$384,0000.05%
FEDERATED HERMES, INC. 29,048,265$8,656,0000.02%
WealthTrust Axiom LLC 68,000$20,0000.01%
All Terrain Financial Advisors, LLC 15,000$4,0000.00%
GYL FINANCIAL SYNERGIES, LLC 34,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 124,056$37,0000.00%
McGuire Investment Group, LLC 15,000$4,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders